ODTX Odyssey Therapeutics, Inc.

Fundamentals / CIK 0001882782 / USD

Odyssey Therapeutics, Inc. reported $438.1M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ODTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for ODTX.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $0 $0 $0 $99K $959K $1.92M
Research & Development $42.12M $36.23M $32.32M $26.32M $30.23M $38.77M
Total Operating Expenses $56.67M $55.47M $39.78M $38.35M $42.88M $41.08M
Operating Income -$56.67M -$55.47M -$39.78M -$38.25M -$41.92M -$39.16M
EBITDA -$55.66M -$54.43M -$38.61M -$37.07M -$40.65M -$37.86M
Interest Income $3.86M $2.83M $1.71M $2.20M $872K $1.16M
Interest Expense $12K $20K $10K $1.0K $2.0K $2.0K
Income Before Tax -$53.01M -$52.80M -$38.20M -$35.52M -$41.20M -$38.30M
Income Tax Expense $49K -$8.0K $63K -$56K $30K $140K
Net Income -$53.06M -$52.79M -$38.26M -$35.46M -$41.23M -$38.44M
Basic EPS -$1.10 -$1.74 -$6.77 -$7.78 -$29.54 -$39.37
Diluted EPS -$1.10 -$1.74 -$6.77 -$7.78 -$29.54 -$39.37
Basic Shares Outstanding 48.0M 30.3M 5.7M 4.6M 1.4M 976.1K
Diluted Shares Outstanding 48.0M 30.3M 5.7M 4.6M 1.4M 976.1K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for ODTX.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $80.64M $82.03M $35.72M $41.69M
Short-Term Investments $245.4M $228.5M $140.0M $139.7M
Cash & Short-Term Investments $326.0M $310.6M $175.7M $181.4M
Accounts Receivable, Net $0 $0 $0 $0
Total Current Assets $337.8M $321.5M $185.1M $190.7M
Property, Plant & Equipment, Net $4.63M $4.88M $6.56M $7.21M
Goodwill $14.12M $14.10M $14.07M $14.33M
Intangible Assets $0 $86K $160K $262K
Long-Term Investments $60.99M $122.5M $0 $35.20M
Other Non-Current Assets $4.43M $3.79M $5.26M $3.33M
Total Non-Current Assets $100.3M $162.4M $43.97M $79.13M
Total Assets $438.1M $483.9M $229.1M $269.8M
Accounts Payable $8.26M $7.67M $8.22M $7.87M
Total Current Liabilities $26.10M $28.30M $22.21M $26.48M
Total Non-Current Liabilities $36.23M $34.33M $27.00M $28.03M
Total Liabilities $62.33M $62.63M $49.21M $54.51M
Total Debt (incl. Leases) $23.48M $24.82M $26.13M $27.11M
Common Stock $5.0K $5.0K $0 $0
Retained Earnings -$712.2M -$659.2M -$606.4M -$568.1M
Accumulated Other Comp. Income -$985K -$505K -$147K $245K
Total Stockholders' Equity $375.8M $421.2M -$523.7M -$488.3M
Total Equity $375.8M $421.2M -$523.7M -$488.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for ODTX.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$53.06M -$52.79M -$38.26M -$35.46M -$41.23M -$38.44M
Depreciation & Amortization $1.01M $1.04M $1.17M $1.19M $1.27M $1.30M
Stock-Based Compensation $7.94M $5.67M $2.59M $4.89M $3.70M $2.99M
Change in Payables $651K -$797K $484K -$678K $278K $713K
Operating Cash Flow -$41.54M -$34.51M -$41.03M -$31.26M -$34.26M -$38.62M
Capital Expenditure -$504K -$186K -$148K -$48K -$29K -$927K
Free Cash Flow -$42.05M -$34.69M -$41.18M -$31.30M -$34.29M -$39.55M
Investing Cash Flow $43.29M -$211.4M $34.80M -$172.9M $23.30M $34.13M
Financing Cash Flow -$3.18M $292.2M $484K $90.78M $118.7M $200K
Net Change in Cash -$1.39M $46.31M -$5.72M -$113.5M $108.1M -$4.22M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for ODTX.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 12.94x 11.36x 8.33x -- -- --
Quick Ratio 12.49x 10.98x 7.91x -- -- --
Debt to Equity 0.06x 0.06x -- -- -- --
Revenue Growth (YoY) -100.0% -100.0% -100.0% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001882782) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:31 UTC · Open in terminal